Our Impact
We work with patients, clinicians, oncologists, pharmaceuticals, biotech companies, and academia.
With ACT Genomics’ expertise in oncology, cancer genomics, and bioinformatics, we are dedicated to meet stringent requirements from our partners to offer comprehensive tumor profiling and extensive bioinformatics expertise.
- Provide comprehensive tumor genomic profiling and generate intuitive and actionable report to identify the right treatment for cancer treatment.
- Enable improved resolution for tumor stratification, therapeutic response studies, and identification of potential biomarker for companion diagnostics.
- Comply with ISO/ CAP regulations for patient stratification in clinical trials to increase the effectiveness of drugs.
Pharmaceuticals
Detailed tumor information for drug development and clinical trials.
Clinicians
Comprehensive actionable variants profiling for targeted cancer therapy.
Academia
Discover biomarkers for predicting drug response and prognosis.